Bone-targeted, nonpeptide inhibitors of the Src SH2 domain: Structure-based design and structure-activity relationships

Regine Bohacek; Manfred Weigele; Virginia Jacobsen; Karina Macek; George Luke; Raji Sundaramoorthi; Chester Metcalf; William Shakespeare; Michael Yang; Yihan Wang; Noriyuki Kawahata; Craig Takeuchi; Chad Haraldson; Vaibhav Varkhedkar; Daniel Johnson; Marcos Hatada; Xiaode Lu; Surinder Narula; Charles Eyermann; Shelia Violette; Catherine Bartlett; Wei Guan; Jeremy Smith; Sue Adams; Berkley Lynch; Ian MacNeil; Marie Rose van Schravendijk; Karin Stebbins; Susan Wood; Ping Li; Ruth Yuan; David Dalgarno; Frank Cerasoli; Tomi Sawyer

Book Chapter

Bone-targeted, nonpeptide inhibitors of the Src SH2 domain: Structure-based design and structure-activity relationships

Bohacek R
Weigele M
Jacobsen V
et al.

Springer Netherlands, (2002), 558-560

DOI: 10.1007/0-306-46881-6_220

N/ACitations

1Readers

Get full text

Abstract

Cite

CITATION STYLE

APA

Bohacek, R., Weigele, M., Jacobsen, V., Macek, K., Luke, G., Sundaramoorthi, R., … Sawyer, T. (2002). Bone-targeted, nonpeptide inhibitors of the Src SH2 domain: Structure-based design and structure-activity relationships. In Peptides for the New Millennium (pp. 558–560). Springer Netherlands. https://doi.org/10.1007/0-306-46881-6_220

Bone-targeted, nonpeptide inhibitors of the Src SH2 domain: Structure-based design and structure-activity relationships

Abstract

Cite

Register to see more suggestions